Gibbs JL, Rothman MT, Rees MR et al (1992) Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J 67:240–245. https://doi.org/10.1136/hrt.67.3.240
Article CAS PubMed PubMed Central Google Scholar
Garg G, Mittal DK (2018) Stenting of patent ductus arteriosus in low birth weight newborns less than 2 kg-procedural safety, feasibility and results in a retrospective study. Indian Heart J 70:709–712. https://doi.org/10.1016/j.ihj.2018.01.027
Article PubMed PubMed Central Google Scholar
Aggarwal V, Petit CJ, Glatz AC et al (2019) Stenting of the ductus arteriosus for ductal-dependent pulmonary blood flow—current techniques and procedural considerations. Congenit Heart Dis 14:110–115. https://doi.org/10.1111/chd.12709
Alwi M, Choo KK, Latiff HA et al (2004) Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 44:438–445. https://doi.org/10.1016/j.jacc.2004.03.066
Mahesh K, Kannan BRJ, Vaidyanathan B et al (2005) Stenting the patent arterial duct to increase pulmonary blood flow. Indian Heart J 57:704–708
Sagar P, Sivakumar K, Umamaheshwar KL et al (2021) Are early palliative procedures providing an adequate long-term benefit in young cyanotic infants from developing countries, despite advances in surgery and interventions? Cardiol Young 31:358–370. https://doi.org/10.1017/S1047951120003947
Bentham JR, Zava NK, Harrison WJ et al (2018) Duct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow. Circulation 137:581–588. https://doi.org/10.1161/CIRCULATIONAHA.117.028972
Ratnayaka K, Nageotte SJ, Moore JW et al (2021) Patent ductus arteriosus stenting for all ductal-dependent cyanotic infants. Circ Cardiovasc Interv 14:e009520. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009520
Haddad RN, Hanna N, Charbel R et al (2019) Ductal stenting to improve pulmonary blood flow in pulmonary atresia with intact ventricular septum and critical pulmonary stenosis after balloon valvuloplasty. Cardiol Young 29:492–498. https://doi.org/10.1017/S1047951119000118
Alsoufi B, Gillespie S, Mori M et al (2016) Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg 50:169–177. https://doi.org/10.1093/ejcts/ezw017
Bauser-Heaton H, Qureshi AM, Goldstein BH et al (2022) Comparison of patent ductus arteriosus stent and Blalock-Taussig shunt as palliation for neonates with sole source ductal-dependent pulmonary blood flow: results from the congenital catheterization research collaborative. Pediatr Cardiol 43:121–131. https://doi.org/10.1007/s00246-021-02699-7
Ghaderian M, Behdad S, Mokhtari M, Salamati L (2023) Comparison of patent ductus arteriosus stenting and Blalock-Taussig shunt in ductal dependent blood flow congenital heart disease and decreased pulmonary blood flow. Heart Views 24:11–16. https://doi.org/10.4103/heartviews.heartviews_84_22
Article PubMed PubMed Central Google Scholar
Tseng SY, Truong VT, Peck D et al (2022) Patent ductus arteriosus stent versus surgical aortopulmonary shunt for initial palliation of cyanotic congenital heart disease with ductal-dependent pulmonary blood flow: a systematic review and meta-analysis. J Am Heart Assoc 11:e024721. https://doi.org/10.1161/JAHA.121.024721
Article PubMed PubMed Central Google Scholar
Alsagheir A, Koziarz A, Makhdoum A et al (2021) Duct stenting versus modified Blalock-Taussig shunt in neonates and infants with duct-dependent pulmonary blood flow: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 161:379-390.e8. https://doi.org/10.1016/j.jtcvs.2020.06.008
Boucek DM, Qureshi AM, Goldstein BH et al (2019) Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: a review of the literature. Congenit Heart Dis 14:105–109. https://doi.org/10.1111/chd.12707
Helal AM, Elmahrouk AF, Bekheet S et al (2022) Patent ductus arteriosus stenting versus modified Blalock-Taussig shunt for palliation of duct-dependent pulmonary blood flow lesions. J Card Surg 37:2571–2580. https://doi.org/10.1111/jocs.16692
Santoro G, Capozzi G, Caianiello G et al (2009) Pulmonary artery growth after palliation of congenital heart disease with duct-dependent pulmonary circulation: arterial duct stenting versus surgical shunt. J Am Coll Cardiol 54:2180–2186. https://doi.org/10.1016/j.jacc.2009.07.043
Shahanavaz S, Qureshi AM, Petit CJ et al (2021) Factors influencing reintervention following ductal artery stent implantation for ductal-dependent pulmonary blood flow: results from the congenital cardiac research collaborative. Circ Cardiovasc Interv 14:e010086. https://doi.org/10.1161/CIRCINTERVENTIONS.120.010086
Kurup HKN, Gopalakrishnan A, Sasikumar D, Krishnamoorthy KM (2023) Safety of drug-eluting stents for stenting patent arterial duct in neonates. Cardiol Young 33:437–443. https://doi.org/10.1017/S104795112200110X
Goldstein BH, O’Byrne ML, Petit CJ et al (2019) Differences in cost of care by palliation strategy for infants with ductal-dependent pulmonary blood flow. Circ Cardiovasc Interv 12:e007232. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007232
Comments (0)